Our Leaders Dan DeNeui Chief Executive Officer | Managing Partner Matthew Davidson Director of Operations Dustin DeNeui Chief Operating Officer Bijal Patel Director of Regulatory Compliance and Quality Justin Graves, RPh Executive Vice President Robert Harris National Director of Growth and Innovations Our Pharmacists Richardson, Texas Abraham Bekele, PharmD Pharmacist in Charge Chioma Jude-Ibe, PharmD Katy Jang, PharmD Justin Pon, PharmD David Uwakwe, PharmD Isabell Dang, PharmD Suneetha Anaparti, PharmD Bao Ngo, PharmD Mary Apiagyei, PharmD Conway, Arkansas Nathan Grifford, PharmD General Manager Matt Wilkins, PharmD Andrew Nichols, PharmD James Murphy, PharmD Athena Lewallen, PharmD Contact Us Give your patients customized compounded medications and personalized customer service with FarmaKeio Custom Compounding
Based on Obesity Canada guidelines and clinical trials (typically over ~1 year): Saxenda: ~58% total body weight loss Wegovy: ~1015% total body weight loss Tirzepatide: ~1520% (or more) total body weight loss weight loss is gradual and occurs over several months, with the most significant changes seen after reaching the full therapeutic dose results vary depending on adherence, lifestyle factors, and individual response 7
Diet plays a role
SongMYKimEKMoonWSParkJWKimHJSoHSet al
Ni H, Chen Y, Xia W, Wang CY, Hu C, Sun L, et al
Insights on the interplay between cells metabolism and signaling: A therapeutic perspective in pediatric acute leukemias
